When Spirair co-founders Brandon McCutcheon, MD and James Kintzing, PhD, began developing SeptAlign™, they needed to find a material that could hold the nasal septum under tension during cartilage remodeling but also resorb within an appropriate time frame.
They shared how they identified the unmet need for a treatment option like SeptAlign, how they selected the material for SeptAlign, and what’s next for Spirair following SeptAlign’s FDA clearance. Read their contributed article in Medical Design & Outsourcing for more.
Spirair and its products may be featured by third-party publications. The opinions and comments expressed by a third party are their own. Spirair does not claim any accuracy of third-party reporting. Individual results may vary depending on the patient’s circumstances and condition.
MRK-022-A
SEPTALIGN™ Indications for Use: SeptAlign™ is used to support and straighten minor deviations in septal cartilage when sufficient healthy cartilage exists, and the cartilage is appropriately mobilized utilizing standard septoplasty techniques.
TURBALIGN™ Indications for Use: TurbAlign™ is intended to separate the middle turbinate from the lateral nasal wall during the clinically relevant healing phase associated with sinus surgery (e.g., endoscopic sinus surgery, FESS). The implant provides short-term fixation of the middle turbinate to the nasal septum and thus minimizes the risk of adherence to the lateral wall.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
SPIRAIR®, SEPTALIGN™ and TURBALIGN™ are trademarks of Spirair Inc.
MRK-010-C Copyright © 2025 Spirair, Inc.
